Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2020);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;9.921;Q1;348;246;675;7779;8359;314;12.06;31.62;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.176;Q1;241;26;65;10316;1366;65;21.62;396.77;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;5.586;Q1;155;128;153;15010;2940;153;19.34;117.27;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;5.06;Q1;80;511;583;18919;6784;572;11.2;37.02;United Kingdom;Western Europe;BMJ Publishing Group;2013-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
5;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;4.968;Q1;210;33;90;4408;1212;90;12.47;133.58;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;4.01;Q1;119;28;52;6414;839;52;17.34;229.07;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;3.878;Q1;225;101;288;6920;3115;276;9.75;68.51;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
8;12455;Molecular Therapy;journal;15250024, 15250016;3.871;Q1;185;222;739;10683;6709;687;8.19;48.12;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;3.475;Q1;331;137;485;28532;6976;443;13.27;208.26;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
10;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.461;Q1;211;152;450;30957;5301;450;11.29;203.66;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
11;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.364;Q1;190;154;527;9455;3496;518;6.29;61.4;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;19600166320;Protein and Cell;journal;16748018, 1674800X;2.973;Q1;74;100;309;4211;1816;195;6.12;42.11;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Cell Biology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
13;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2.928;Q1;233;313;877;35261;7160;869;8.36;112.65;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.868;Q1;134;81;162;16520;1959;157;11.93;203.95;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.704;Q1;227;286;894;16878;5335;815;5.53;59.01;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
16;26371;Natural Product Reports;journal;02650568, 14604752;2.703;Q1;188;73;196;12696;2192;189;11.22;173.92;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
17;21100850730;npj Vaccines;journal;20590105;2.691;Q1;30;105;134;5348;860;133;6.09;50.93;United Kingdom;Western Europe;Nature Publishing Group;2016-2021;"Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
18;21100207003;Theranostics;journal;18387640;2.689;Q1;115;842;1347;57509;14419;1327;10.54;68.3;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
19;18148;Pain;journal;18726623, 03043959;2.524;Q1;269;310;943;6650;5030;797;5.23;21.45;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
20;5100155080;Neurotherapeutics;journal;19337213;2.496;Q1;122;158;292;13813;2004;266;6.35;87.42;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
21;21100232818;Emerging Microbes and Infections;journal;22221751;2.475;Q1;68;303;489;10411;2796;413;5.8;34.36;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
22;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.432;Q1;223;388;1012;28322;7611;955;7.09;72.99;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
23;21100819608;Emerging Contaminants;journal;24056650, 24056642;2.343;Q1;24;46;53;2977;482;52;3.84;64.72;China;Asiatic Region;KeAi Communications Co.;2015-2021;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
24;21100225611;Advanced healthcare materials;journal;21922640, 21922659;2.288;Q1;105;334;994;26795;8737;975;8.9;80.22;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
25;21101018849;ACS Pharmacology and Translational Science;journal;25759108;2.271;Q1;20;132;64;8523;222;56;3.47;64.57;United States;Northern America;American Chemical Society;2018-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;2.255;Q1;70;38;115;1567;585;113;4.79;41.24;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
27;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.208;Q1;71;378;670;18758;5196;665;8.04;49.62;United States;Northern America;Cell Press;2012-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
28;23916;Environmental Pollution;journal;02697491, 18736424;2.136;Q1;249;2105;4202;129459;35114;4167;7.97;61.5;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
29;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.124;Q1;203;526;1711;15215;8181;1497;4.6;28.93;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;23010;Journal of Controlled Release;journal;18734995, 01683659;2.119;Q1;282;541;1475;46929;13078;1397;8.69;86.74;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
31;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.07;Q1;269;744;2638;26662;12780;2505;4.45;35.84;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;19617;Antiviral Research;journal;01663542, 18729096;2.052;Q1;134;212;683;10700;3916;683;5.69;50.47;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q1)"
33;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.01;Q1;276;907;2119;60648;14196;2105;6.73;66.87;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
34;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.99;Q1;143;964;2481;46207;11267;2435;4.18;47.93;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
35;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.964;Q1;94;103;291;12152;1572;257;5.23;117.98;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
36;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.955;Q1;82;78;282;11625;1925;257;6.37;149.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
37;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.941;Q1;195;323;903;10846;3988;680;4.09;33.58;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
38;20051;BioDrugs;journal;11738804, 1179190X;1.919;Q1;71;62;166;4406;940;151;4.65;71.06;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
39;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.912;Q1;65;184;276;13417;2585;262;10.49;72.92;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
40;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.897;Q1;113;52;308;3134;1516;298;4.56;60.27;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
41;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;1.868;Q1;139;108;343;6569;1731;306;4.8;60.82;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
42;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.864;Q1;91;94;314;8262;1546;289;4.68;87.89;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Immunology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
43;21169;Pharmacological Research;journal;10436618, 10961186;1.85;Q1;147;599;1050;58612;7119;973;6.68;97.85;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
44;21165;PharmacoEconomics;journal;11707690, 11792027;1.809;Q1;104;112;359;4864;1338;314;3.68;43.43;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
45;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.805;Q1;97;44;149;1314;684;149;4.23;29.86;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
46;26380;Drug and Alcohol Dependence;journal;03768716;1.783;Q1;173;541;1407;24672;5946;1398;3.95;45.6;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
47;21196;Drug Discovery Today;journal;18785832, 13596446;1.778;Q1;185;249;666;18949;5060;629;7.04;76.1;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
48;20435;Neuropharmacology;journal;00283908, 18737064;1.76;Q1;176;417;1334;35084;6627;1308;4.65;84.13;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
49;21100875801;npj Systems Biology and Applications;journal;20567189;1.752;Q1;25;33;114;1694;465;114;4.05;51.33;United Kingdom;Western Europe;Nature Publishing Group;2015-2021;"Applied Mathematics (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Computer Science Applications (Q1); Drug Discovery (Q1); Modeling and Simulation (Q1)"
50;4400151524;Particle and Fibre Toxicology;journal;17438977;1.748;Q1;105;61;145;4821;1250;143;8.39;79.03;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
51;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.716;Q1;134;204;751;16345;3502;740;4.63;80.12;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
52;15984;Journal of Molecular Medicine;journal;09462716, 14321440;1.708;Q1;146;132;368;8826;1763;349;3.99;66.86;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
53;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.684;Q1;56;70;188;3450;1000;174;5.42;49.29;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
54;21207;Drug Discovery Today: Technologies;journal;17406749;1.676;Q1;53;29;96;1944;492;86;5.51;67.03;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q1); Drug Discovery (Q1); Molecular Medicine (Q1)"
55;16088;Journal of Nanobiotechnology;journal;14773155;1.629;Q1;84;169;315;9709;2984;313;9.68;57.45;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
56;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.605;Q1;96;105;380;11026;1261;30;2.93;105.01;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
57;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.603;Q1;118;150;381;9206;1514;369;3.58;61.37;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
58;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.595;Q1;206;482;990;36410;5492;980;5.21;75.54;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
59;21100857212;Current Opinion in Systems Biology;journal;24523100;1.576;Q1;26;43;269;2736;734;239;2.66;63.63;United Kingdom;Western Europe;Elsevier Ltd.;2017-2021;"Applied Mathematics (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Computer Science Applications (Q1); Drug Discovery (Q1); Modeling and Simulation (Q1)"
60;144771;Clinical Trials;journal;17407753, 17407745;1.559;Q1;67;94;255;2273;480;213;1.69;24.18;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
61;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.549;Q1;169;121;362;6486;1801;329;4.81;53.6;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
62;24763;Addictive Behaviors;journal;03064603;1.52;Q1;135;345;1180;16254;4477;1148;3.31;47.11;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
63;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.514;Q1;98;170;503;9375;2829;495;5.06;55.15;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
64;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.513;Q1;89;16;53;2147;329;49;5.2;134.19;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
65;22378;Vascular Pharmacology;journal;18793649, 15371891;1.479;Q1;100;48;205;2358;1039;203;5.35;49.13;United States;Northern America;Elsevier Inc.;2002-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Physiology (Q1)"
66;19963;Molecular Pharmacology;journal;15210111, 0026895X;1.469;Q1;202;118;399;6604;1484;397;3.79;55.97;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
67;24749;Addiction Biology;journal;13556215, 13691600;1.445;Q1;83;142;367;7636;1405;363;3.44;53.77;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
68;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.421;Q1;39;78;159;1854;279;151;1.51;23.77;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q1)"
69;145164;Human Genomics;journal;14739542, 14797364;1.414;Q1;59;44;151;2229;596;149;3.88;50.66;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
70;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.41;Q1;109;132;336;11059;1593;321;4.84;83.78;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
71;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.403;Q1;75;132;376;6059;1606;330;3.97;45.9;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Physiology (medical) (Q1); Psychiatry and Mental Health (Q1)"
72;21100214102;Frontiers in Pharmacology;journal;16639812;1.384;Q1;104;2213;3985;146226;21528;3917;5.24;66.08;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
73;21782;Psychopharmacology;journal;00333158, 14322072;1.378;Q1;202;300;880;18064;3210;849;3.8;60.21;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
74;21237;Drug Safety;journal;01145916, 11791942;1.377;Q1;131;126;372;5175;1374;313;3.96;41.07;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
75;25218;Toxicological Sciences;journal;10960929, 10966080;1.352;Q1;193;196;847;11031;3547;788;4.18;56.28;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
76;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.333;Q1;121;143;444;8729;1633;428;3.5;61.04;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
77;28620;Biomedicine and Pharmacotherapy;journal;07533322;1.323;Q1;109;1306;4830;80962;28246;4813;6.03;61.99;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
78;4200151509;Molecular Diagnosis and Therapy;journal;11771062;1.322;Q1;47;62;190;4016;706;183;3.61;64.77;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
79;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.318;Q1;115;68;258;3690;1205;251;3.64;54.26;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
80;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.316;Q1;68;123;319;12439;1654;266;4.52;101.13;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q1)
81;21100904379;Nanotheranostics;journal;22067418;1.31;Q1;20;22;89;1065;488;88;5;48.41;Australia;Pacific Region;Ivyspring International Publishers;2017-2021;"Biomedical Engineering (Q1); Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
82;19700174918;Clinical and Translational Science;journal;17528062, 17528054;1.303;Q1;48;155;226;5310;799;191;3.51;34.26;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
83;21100335701;Vaccines;journal;2076393X;1.296;Q1;50;780;344;49148;1482;333;4.11;63.01;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2013-2021;"Drug Discovery (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
84;17700156714;Pharmaceuticals;journal;14248247;1.295;Q1;69;483;414;37527;2240;403;5.58;77.7;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
85;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.286;Q1;233;183;675;9767;2588;666;3.53;53.37;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
86;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.279;Q1;177;274;1068;15749;4941;1053;4.48;57.48;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
87;20578;Journal of Food and Drug Analysis;journal;10219498;1.277;Q1;63;51;352;3112;2341;350;6.05;61.02;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q1); Pharmacology (Q1)"
88;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.267;Q1;159;252;721;13877;2128;666;2.7;55.07;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
89;24604;Archives of Toxicology;journal;14320738, 03405761;1.264;Q1;121;290;826;19760;4002;725;4.2;68.14;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
90;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.263;Q1;133;185;692;10149;4174;686;5.93;54.86;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
91;4700152278;Drugs in Context;journal;17404398, 17451981;1.262;Q1;26;69;108;3474;567;108;5.73;50.35;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
92;22477;Investigational New Drugs;journal;01676997, 15730646;1.254;Q1;90;188;363;6128;1268;362;3.25;32.6;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
93;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.245;Q1;145;678;1917;40758;12706;1911;5.93;60.12;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Nanoscience and Nanotechnology (Q2)"
94;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.219;Q1;77;69;162;6497;584;149;3.05;94.16;United States;Northern America;Springer New York;2006-2021;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
95;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.216;Q1;153;274;935;10971;3141;785;3.1;40.04;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
96;20770;Drug Delivery;journal;10717544, 15210464;1.189;Q1;72;154;501;8061;3111;501;6.09;52.34;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
97;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.184;Q1;139;151;366;11519;1190;361;3.23;76.28;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
98;19700201201;EPMA Journal;journal;18785077, 18785085;1.177;Q1;39;39;108;4020;638;106;6.27;103.08;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Health Policy (Q1)"
99;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.177;Q1;175;838;2852;56099;17214;2850;6.15;66.94;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
100;5400152706;Nanotoxicology;journal;17435390, 17435404;1.176;Q1;94;87;260;5109;1615;257;5.53;58.72;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
101;21100788744;OpenNano;journal;23529520;1.168;Q1;14;0;20;0;188;20;9;0;United States;Northern America;Elsevier Inc.;2016-2019;"Biotechnology (Q1); Internal Medicine (Q1); Pharmaceutical Science (Q1); Pharmacology (medical) (Q1)"
102;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.166;Q1;120;145;427;5395;1737;423;4.06;37.21;United States;Northern America;Landes Bioscience;2002-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
103;4700152848;PPAR Research;journal;16874757, 16874765;1.164;Q1;52;29;57;2019;238;56;3.59;69.62;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
104;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.161;Q1;78;106;317;3201;1030;297;3.02;30.2;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
105;21100892509;Cannabis and Cannabinoid Research;journal;23788763;1.156;Q1;29;41;93;1733;599;89;4.39;42.27;United States;Northern America;Mary Ann Liebert Inc.;2016-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
106;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.155;Q1;96;102;230;4450;1004;225;4.5;43.63;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
107;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.153;Q1;229;1054;2543;58479;14817;2531;5.75;55.48;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
108;22432;International Immunopharmacology;journal;18781705, 15675769;1.152;Q1;119;990;1520;49956;6903;1513;4.42;50.46;Netherlands;Western Europe;Elsevier;2001-2021;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
109;20473;Life Sciences;journal;18790631, 00243205;1.131;Q1;174;1280;1884;79355;8510;1882;4.58;62;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
110;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.13;Q1;138;408;1439;22045;7007;1427;4.62;54.03;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
111;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.126;Q1;66;222;452;4966;1219;430;2.35;22.37;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
112;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.121;Q1;77;71;253;6591;1409;243;6.11;92.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
113;22410;Inflammation Research;journal;1420908X, 10233830;1.121;Q1;94;116;293;6165;1217;288;4.14;53.15;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q1); Immunology (Q2)"
114;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.112;Q1;114;195;747;6516;2281;733;2.87;33.42;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
115;4000148019;AAPS Journal;journal;15507416;1.109;Q1;118;139;385;5759;1498;370;3.51;41.43;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
116;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.108;Q1;71;97;214;3942;788;190;2.78;40.64;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
117;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.105;Q1;39;53;151;1726;502;139;3.5;32.57;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
118;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.103;Q1;168;259;849;14522;4799;844;5.37;56.07;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
119;21100258853;F1000Research;journal;20461402;1.099;Q1;72;669;2490;30791;6990;2408;2.43;46.03;United Kingdom;Western Europe;;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2)"
120;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.092;Q1;117;52;122;5867;576;121;4.53;112.83;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
121;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.088;Q1;91;150;427;11558;1575;395;3.65;77.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
122;84948;Expert Opinion on Drug Delivery;journal;17425247;1.084;Q1;116;134;320;12120;1839;291;5.85;90.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
123;10900153302;Biomarker Insights;journal;11772719;1.075;Q1;35;17;59;1317;278;58;5.65;77.47;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
124;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.071;Q1;40;52;162;3156;630;160;3.99;60.69;Netherlands;Western Europe;Elsevier BV;2011-2021;"Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2)"
125;25219;Toxicology;journal;0300483X, 18793185;1.067;Q1;165;155;506;8548;2231;494;3.83;55.15;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
126;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.066;Q1;95;72;192;4198;479;189;2.47;58.31;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
127;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.065;Q1;73;384;763;10787;2876;732;3.61;28.09;United States;Northern America;American Chemical Society;2010-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
128;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;1.065;Q1;57;175;566;5785;1689;533;2.93;33.06;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Environmental Chemistry (Q2)"
129;18073;NeuroToxicology;journal;18729711, 0161813X;1.06;Q1;122;166;492;8782;1867;455;3.91;52.9;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
130;19700188360;Pharmaceutics;journal;19994923;1.054;Q1;68;1241;1030;86863;6587;1021;6.11;69.99;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q1)
131;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.051;Q1;30;9;22;545;157;22;6.14;60.56;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
132;19700188352;Toxins;journal;20726651;1.047;Q1;91;807;1706;48157;7401;1671;4.19;59.67;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
133;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.046;Q1;189;667;1780;39662;7076;1777;4.07;59.46;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
134;17067;Phytomedicine;journal;09447113, 1618095X;1.045;Q1;127;219;908;10856;4470;897;4.99;49.57;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
135;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;1.043;Q1;69;460;1236;18449;3520;1020;2.73;40.11;United States;Northern America;Landes Bioscience;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
136;19700175015;Infection and Drug Resistance;journal;11786973;1.033;Q1;44;465;707;20182;2818;690;3.81;43.4;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q1); Infectious Diseases (Q2); Pharmacology (medical) (Q2)"
137;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.031;Q1;163;292;619;17696;2244;595;3.24;60.6;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
138;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.031;Q1;88;96;323;10869;1276;299;3.84;113.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1); Pharmacology (Q2)"
139;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.028;Q1;53;111;174;5334;576;153;3.4;48.05;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
140;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.026;Q1;129;105;347;4039;682;288;1.67;38.47;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Toxicology (Q1); Psychiatry and Mental Health (Q2)"
141;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.025;Q1;182;146;513;6847;1726;507;3.33;46.9;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
142;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.023;Q1;100;27;78;3586;420;78;4.44;132.81;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
143;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;1.021;Q1;48;64;190;4424;1092;188;6.27;69.13;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
144;16573;Phytotherapy Research;journal;10991573, 0951418X;1.019;Q2;140;267;724;18550;3751;713;5.4;69.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
145;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.017;Q1;175;302;925;16368;3650;921;3.88;54.2;United States;Northern America;Academic Press Inc.;1959-2021;"Toxicology (Q1); Pharmacology (Q2)"
146;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;1.014;Q1;46;125;360;10841;1314;317;4.07;86.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
147;21100367469;Toxicology Reports;journal;22147500;1.013;Q1;46;197;388;10461;1982;382;4.84;53.1;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
148;25240;Toxicology Letters;journal;03784274, 18793169;1.007;Q1;150;303;840;14151;3442;821;3.95;46.7;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
149;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.985;Q2;87;101;361;3788;1219;361;3.15;37.5;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
150;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.977;Q1;44;65;220;3389;830;219;4.36;52.14;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
151;23053;Journal of Natural Products;journal;01633864, 15206025;0.976;Q1;147;425;1179;16165;4726;1168;3.74;38.04;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
152;26767;Altex;journal;1868596X, 18688551;0.975;Q2;57;67;157;2334;528;135;3.08;34.84;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
153;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.975;Q2;51;41;78;4420;264;76;3.54;107.8;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
154;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.975;Q1;32;131;251;6220;781;246;2.56;47.48;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
155;6400153120;Chinese Medicine;journal;17498546;0.972;Q2;45;127;152;7789;768;150;5.59;61.33;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
156;29311;Current Cancer Drug Targets;journal;15680096, 18735576;0.972;Q1;96;75;237;5949;723;219;3.1;79.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
157;19700175230;Drug Design, Development and Therapy;journal;11778881;0.964;Q1;71;465;1081;20605;4491;1067;3.81;44.31;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
158;21100469670;Antibiotics;journal;20796382;0.96;Q1;47;926;416;54170;1899;408;4.39;58.5;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Infectious Diseases (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (medical) (Q2)"
159;21100829975;Clinical and Experimental Vaccine Research;journal;2287366X, 22873651;0.958;Q2;13;24;57;599;153;55;1.89;24.96;South Korea;Asiatic Region;Korean Vaccine Society;2017-2021;"Public Health, Environmental and Occupational Health (Q1); Immunology and Allergy (Q2); Infectious Diseases (Q2); Pharmacology (Q2)"
160;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.951;Q1;183;754;2057;42421;9152;2025;4.38;56.26;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Toxicology (Q1); Medicine (miscellaneous) (Q2)"
161;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.947;Q2;103;47;168;3313;563;158;3.39;70.49;United States;Northern America;Elsevier Inc.;1987-2021;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
162;22411;Inflammopharmacology;journal;09254692, 15685608;0.945;Q2;55;122;303;7731;1277;302;3.98;63.37;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
163;24652;Chemico-Biological Interactions;journal;00092797;0.943;Q2;128;281;957;15364;4441;946;4.78;54.68;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
164;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.935;Q1;57;157;1197;4796;6096;1195;5.18;30.55;United States;Northern America;Informa Healthcare;2013-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
165;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;0.935;Q2;43;11;52;31;140;48;2.61;2.82;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Virology (Q3)"
166;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;0.934;Q1;183;382;1048;47182;4063;959;3.66;123.51;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
167;21100804457;Current Opinion in Toxicology;journal;24682020;0.932;Q2;27;58;197;2807;689;183;4.04;48.4;Netherlands;Western Europe;Elsevier BV;2016-2021;Toxicology (Q2)
168;29712;Clinical Therapeutics;journal;1879114X, 01492918;0.925;Q2;140;221;672;8959;1756;587;2.32;40.54;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.924;Q2;88;175;583;9832;2685;581;4.61;56.18;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
170;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.923;Q2;90;65;288;5920;1039;266;3.8;91.08;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
171;18071;Neurotoxicity Research;journal;14763524, 10298428;0.923;Q2;78;178;414;10515;1431;414;3.45;59.07;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q2); Neuroscience (miscellaneous) (Q3)"
172;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.92;Q2;31;0;80;0;238;80;2.12;0;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q2); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3)"
173;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.92;Q2;121;184;550;6994;1410;519;2.55;38.01;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
174;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.919;Q1;54;14;34;711;134;31;5;50.79;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
175;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.916;Q2;79;185;471;9396;2393;471;4.75;50.79;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
176;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.907;Q2;79;0;13;0;38;12;0;0;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
177;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.893;Q2;34;11;44;290;111;44;2.54;26.36;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
178;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.89;Q1;95;111;284;8117;1320;276;4.7;73.13;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
179;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.89;Q2;112;217;755;9586;2485;684;2.91;44.18;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
180;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.889;Q1;29;15;32;872;169;30;4.41;58.13;United States;Northern America;Springer Science + Business Media;2010-2021;"Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Biomedical Engineering (Q2); Oncology (Q2)"
181;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.889;Q2;72;185;528;8151;1644;524;3.19;44.06;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
182;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.885;Q2;205;846;1574;51954;6863;1565;4.25;61.41;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
183;19700175819;Patient Preference and Adherence;journal;1177889X;0.885;Q1;54;232;681;9520;1863;672;2.45;41.03;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Health Policy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Medicine (miscellaneous) (Q2)"
184;21264;Drugs in R and D;journal;11796901, 11745886;0.873;Q2;47;37;131;1464;375;127;2.37;39.57;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q2)
185;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.873;Q2;83;230;647;16897;1828;568;2.77;73.47;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
186;21100197929;Toxicological Research;journal;19768257, 22342753;0.872;Q2;35;42;122;1515;423;122;3.42;36.07;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.855;Q2;93;96;345;7331;1286;343;4.28;76.36;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Organic Chemistry (Q1); Drug Discovery (Q2); Molecular Medicine (Q2)"
188;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.853;Q2;50;477;392;21486;1219;383;2.84;45.04;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q2); Pharmacology (Q2)"
189;144790;Marine Drugs;journal;16603397;0.848;Q2;128;661;1623;35905;8018;1619;4.81;54.32;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
190;21100811517;Birth Defects Research;journal;24721727;0.845;Q2;25;146;414;8485;900;373;1.84;58.12;United Kingdom;Western Europe;John Wiley and Sons Ltd;2017-2021;"Pediatrics, Perinatology and Child Health (Q1); Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
191;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.845;Q2;114;205;604;6946;1414;516;2.12;33.88;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
192;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.845;Q2;31;70;89;3488;326;88;3.74;49.83;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
193;24028;Reproductive Toxicology;journal;08906238, 18731708;0.845;Q2;117;163;455;9574;1546;437;2.86;58.74;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
194;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.844;Q2;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
195;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.842;Q2;64;49;126;2594;555;102;4.99;52.94;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
196;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.84;Q2;98;211;486;4600;1095;333;2.3;21.8;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
197;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.84;Q1;144;367;1337;20059;5864;1326;4.19;54.66;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
198;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.839;Q2;81;92;271;4341;806;271;2.93;47.18;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q2)"
199;25171;Mycotoxin Research;journal;18671632, 01787888;0.839;Q2;40;42;106;2092;486;106;3.75;49.81;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
200;25224;Toxicology in Vitro;journal;18793177, 08872333;0.834;Q2;112;268;790;13047;2733;778;3.21;48.68;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
201;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.829;Q2;39;35;78;1600;353;77;4.75;45.71;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q2); Toxicology (Q2)"
202;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.827;Q2;115;104;336;5828;1009;334;2.81;56.04;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
203;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.827;Q2;64;48;162;2283;333;157;2.03;47.56;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
204;20664;Current Drug Targets;journal;18735592, 13894501;0.826;Q2;107;141;448;15650;1455;420;2.98;110.99;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
205;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.822;Q1;38;0;52;0;247;51;4.68;0;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
206;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.818;Q2;48;61;160;3026;403;151;2.4;49.61;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;4400151608;ChemMedChem;journal;18607187, 18607179;0.817;Q1;106;256;692;13224;2204;684;3.16;51.66;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
208;21123;Pharmaceutical Research;journal;07248741, 1573904X;0.815;Q1;213;240;665;11466;2622;649;3.76;47.78;United States;Northern America;Springer New York;1984-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
209;25093;Environmental Toxicology;journal;15227278, 15204081;0.813;Q2;81;136;474;6104;1657;472;3.72;44.88;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
210;19700170617;EXCLI Journal;journal;16112156;0.812;Q2;43;148;320;6772;1061;258;3.05;45.76;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
211;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.81;Q2;76;61;164;4398;488;163;2.92;72.1;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
212;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.806;Q2;63;76;225;5973;606;197;2.13;78.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
213;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.805;Q2;93;137;513;5784;1415;488;2.97;42.22;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
214;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;0.804;Q2;90;88;233;4015;725;227;3.07;45.63;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
215;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.803;Q2;66;1021;1333;48190;6738;1332;4.95;47.2;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
216;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.796;Q1;69;212;621;4823;1083;488;1.34;22.75;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Education (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1); Medicine (miscellaneous) (Q2)"
217;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.787;Q2;52;63;188;2781;464;178;2.02;44.14;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.786;Q1;38;65;167;3673;748;166;4.5;56.51;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Electrochemistry (Q2); Spectroscopy (Q2)"
219;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.784;Q2;91;129;430;7416;1481;429;3.25;57.49;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
220;21100830708;Toxics;journal;23056304;0.783;Q2;32;124;172;7756;719;166;3.94;62.55;Switzerland;Western Europe;MDPI AG;2013-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
221;26370;Molecules;journal;14203049;0.782;Q1;171;6248;10347;334570;43933;10295;4.18;53.55;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
222;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.777;Q1;133;686;1950;23869;6988;1943;3.77;34.79;Netherlands;Western Europe;Elsevier;1983-2022;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
223;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.776;Q1;186;388;1191;17969;4158;1128;3.42;46.31;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
224;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.773;Q1;42;80;239;4247;994;233;3.43;53.09;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;"Pharmaceutical Science (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
225;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.771;Q1;25;26;56;986;194;55;3.2;37.92;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q1); Pharmacology (nursing) (Q1); Physical Therapy, Sports Therapy and Rehabilitation (Q2); Public Health, Environmental and Occupational Health (Q2); Sports Science (Q2)"
226;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.762;Q2;104;154;323;1287;797;297;2.36;8.36;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
227;21100824046;Computational Toxicology;journal;24681113;0.754;Q2;15;26;106;1301;315;104;2.6;50.04;Netherlands;Western Europe;Elsevier BV;2017-2021;"Computer Science Applications (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
228;21100977423;RSC Medicinal Chemistry;journal;26328682;0.754;Q1;62;104;622;6317;2084;615;3.3;60.74;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
229;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.753;Q2;113;147;359;8813;1155;358;3.17;59.95;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Animal Science and Zoology (Q1); Aquatic Science (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
230;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.752;Q2;107;210;455;9394;1142;421;2.28;44.73;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
231;24785;Alcohol;journal;07418329;0.75;Q2;83;112;272;5532;620;266;1.93;49.39;United States;Northern America;Elsevier Inc.;1984-2021;"Biochemistry (Q2); Health (social science) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Neurology (Q3)"
232;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.749;Q2;104;94;265;5347;823;258;3.22;56.88;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
233;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.747;Q2;103;87;303;3137;649;273;2.13;36.06;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q2); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
234;21790;Antiviral Therapy;journal;20402058, 13596535;0.747;Q2;89;21;252;762;473;243;2.09;36.29;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
235;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.745;Q1;69;73;139;2674;378;130;3;36.63;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
236;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.745;Q1;31;46;159;2939;715;158;5.3;63.89;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
237;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.745;Q1;124;169;500;8431;1650;494;3.33;49.89;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
238;21100238633;BioImpacts;journal;22285652, 22285660;0.743;Q1;37;35;94;1323;380;91;3.55;37.8;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Pharmaceutical Science (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
239;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.741;Q2;32;40;122;1498;402;122;3.23;37.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
240;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.74;Q2;85;53;190;2972;344;185;1.92;56.08;United States;Northern America;Wiley-Blackwell;1918-2021;"Inorganic Chemistry (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
241;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.732;Q2;46;144;322;8951;1220;315;4.03;62.16;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q2)
242;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;0.73;Q2;76;18;43;2951;192;43;4.78;163.94;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
243;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.728;Q2;27;145;154;7946;726;151;4.58;54.8;Netherlands;Western Europe;Elsevier BV;2015-2021;"Environmental Chemistry (Q2); Management, Monitoring, Policy and Law (Q2); Pharmaceutical Science (Q2); Pollution (Q2)"
244;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.727;Q2;64;98;279;3626;582;254;2.09;37;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.724;Q2;58;67;180;2419;520;107;2.94;36.1;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
246;21100896684;International Journal of Pharmaceutics: X;journal;25901567;0.724;Q2;12;21;36;867;130;36;3.61;41.29;Netherlands;Western Europe;Elsevier BV;2019-2021;Pharmaceutical Science (Q2)
247;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.723;Q2;56;60;175;2591;513;175;2.79;43.18;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
248;18966;Mutagenesis;journal;02678357, 14643804;0.723;Q2;95;45;140;2877;478;137;2.6;63.93;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
249;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.721;Q2;171;422;1754;19415;5843;1741;3.4;46.01;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
250;25075;Ecotoxicology;journal;09639292, 15733017;0.72;Q2;97;161;373;10189;1020;370;2.6;63.29;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
251;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.719;Q1;59;126;608;5790;1433;601;2.25;45.95;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
252;19600166302;Current Molecular Pharmacology;journal;18744702;0.717;Q2;42;32;89;2336;246;81;3.1;73;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
253;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.716;Q2;63;90;189;3196;488;183;2.42;35.51;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
254;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.715;Q2;18;75;127;2086;136;117;0.99;27.81;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q2); Statistics and Probability (Q2)"
255;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.714;Q2;92;59;331;3459;820;321;2.3;58.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
256;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.711;Q2;83;77;224;4341;500;216;2.14;56.38;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
257;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.711;Q2;26;100;276;2517;531;260;1.91;25.17;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
258;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.71;Q2;46;26;89;2460;293;85;3.71;94.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
259;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.71;Q2;54;240;514;10092;1311;404;2.4;42.05;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
260;21100241601;Toxicology Research;journal;2045452X, 20454538;0.709;Q2;37;72;298;3543;958;295;3.23;49.21;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
261;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.708;Q2;76;160;591;9033;1784;542;2.79;56.46;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
262;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.706;Q2;122;240;735;21751;2214;620;2.56;90.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
263;130063;Pharmacological Reports;journal;17341140;0.706;Q2;87;152;526;8376;1568;524;2.7;55.11;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
264;22205;Saudi Pharmaceutical Journal;journal;13190164;0.706;Q2;57;217;484;10105;2136;484;4.43;46.57;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
265;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.705;Q2;29;62;221;3036;570;215;2.25;48.97;Egypt;Africa/Middle East;Hindawi Limited;2013-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3)"
266;22072;Current Gene Therapy;journal;18755631, 15665232;0.704;Q2;75;38;129;2994;386;113;3.14;78.79;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
267;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.703;Q2;78;30;118;1279;361;114;3.07;42.63;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
268;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.702;Q2;72;147;469;5933;1721;468;3.42;40.36;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
269;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.701;Q2;53;70;188;3465;473;184;2.26;49.5;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
270;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.693;Q2;90;150;439;7079;821;429;1.78;47.19;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
271;20682;Current Pharmaceutical Design;journal;13816128, 18734286;0.69;Q2;166;515;1637;53247;4742;1517;2.63;103.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
272;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.689;Q2;94;120;158;4072;416;154;2.89;33.93;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
273;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.685;Q1;33;60;175;2018;545;175;3.09;33.63;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
274;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.678;Q2;17;184;397;6865;645;390;1.69;37.31;United States;Northern America;Elsevier Inc.;2015-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
275;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.678;Q2;73;41;124;1303;297;117;2.14;31.78;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
276;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.672;Q3;40;21;62;1007;183;62;2.86;47.95;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
277;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.67;Q2;93;222;388;10541;936;372;2.56;47.48;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
278;20663;Current Drug Metabolism;journal;18755453, 13892002;0.667;Q2;111;115;341;8505;1132;308;3.36;73.96;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmacology (Q2); Clinical Biochemistry (Q3)"
279;59665;Chinese Journal of Natural Medicines;journal;16723651;0.664;Q2;40;107;318;4850;912;313;2.85;45.33;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
280;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.663;Q2;52;658;1051;39428;4049;1050;3.91;59.92;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
281;21100862294;Neuropsychopharmacology Reports;journal;2574173X;0.661;Q2;14;61;69;1641;123;68;1.78;26.9;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
282;25109;Inhalation Toxicology;journal;08958378, 10917691;0.66;Q3;90;48;172;2388;390;162;2.19;49.75;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
283;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.655;Q2;77;79;222;3170;556;205;2.16;40.13;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
284;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.653;Q2;67;283;534;7471;1001;446;1.41;26.4;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
285;19374;AAPS PharmSciTech;journal;15309932;0.652;Q2;101;314;1023;15122;3322;1011;3.27;48.16;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
286;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.652;Q2;49;156;420;7074;935;393;2.11;45.35;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Drug Discovery (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3)"
287;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.651;Q2;96;158;377;4548;863;376;2.1;28.78;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
288;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.649;Q2;96;130;303;1266;739;284;2.56;9.74;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
289;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.645;Q2;47;70;121;3671;359;117;2.61;52.44;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
290;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.644;Q1;21;70;102;2405;206;94;2.23;34.36;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1); Health Policy (Q2)"
291;16067;Reading Teacher;journal;00340561;0.642;Q2;53;94;297;2131;279;258;0.86;22.67;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
292;21100932732;PharmacoEconomics - Open;journal;25094262, 25094254;0.637;Q2;13;47;135;1744;249;120;1.74;37.11;Switzerland;Western Europe;Springer Nature Switzerland AG;2017-2021;"Health Policy (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
293;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.635;Q2;122;285;882;10145;1993;871;2.13;35.6;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
294;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.634;Q3;80;182;597;7155;1724;594;2.91;39.31;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q2); Food Science (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
295;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.633;Q1;23;198;567;4543;829;518;1.41;22.94;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1)"
296;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;0.633;Q3;26;42;111;2112;371;111;2.9;50.29;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry (Q2); Food Science (Q2); Organic Chemistry (Q2); Plant Science (Q2); Biochemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
297;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.628;Q2;90;200;615;9321;1957;614;3.02;46.61;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
298;18077;Fitoterapia;journal;0367326X, 18736971;0.624;Q2;110;268;798;11112;2215;798;2.69;41.46;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
299;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.624;Q1;61;94;316;4908;793;268;2.44;52.21;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Veterinary (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
300;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.622;Q3;76;215;412;6980;879;377;2.09;32.47;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
301;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.62;Q2;65;72;241;2866;865;229;3.31;39.81;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
302;130031;Journal of Toxicologic Pathology;journal;09149198;0.619;Q3;30;36;120;990;201;120;1.54;27.5;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
303;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.619;Q2;52;66;250;3504;679;226;2.47;53.09;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q2)
304;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.618;Q3;34;88;258;3326;656;258;2.44;37.8;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
305;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.617;Q2;154;655;2290;20155;6142;2289;2.62;30.77;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
306;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.613;Q2;91;147;486;5061;1182;486;2.34;34.43;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Biophysics (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Immunology (Q4)"
307;25214;Toxicologic Pathology;journal;15331601, 01926233;0.613;Q3;112;88;295;4531;502;282;1.62;51.49;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Cell Biology (Q3); Molecular Biology (Q3); Toxicology (Q3)"
308;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.611;Q2;44;221;571;10971;1592;565;2.69;49.64;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biophysics (Q2); Drug Discovery (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
309;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.608;Q2;28;82;170;3164;381;164;1.87;38.59;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
310;21100455212;Biomedical Reports;journal;20499434, 20499442;0.607;Q2;29;138;363;5965;716;363;1.96;43.22;Greece;Western Europe;Spandidos Publications;2014-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
311;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.603;Q2;95;149;357;14217;1223;338;3.52;95.42;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4)"
312;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.601;Q3;42;38;100;1588;244;100;2.31;41.79;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
313;20634;Journal of Texture Studies;journal;00224901, 17454603;0.593;Q2;57;88;201;3766;501;191;2.63;42.8;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
314;4000150314;Chemical Biology and Drug Design;journal;17470277;0.59;Q2;82;121;599;5669;1543;537;2.56;46.85;United Kingdom;Western Europe;Blackwell;2006-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
315;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.586;Q3;26;23;92;922;221;84;3;40.09;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Radiology, Nuclear Medicine and Imaging (Q2); Pharmacology (Q3)"
316;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.585;Q3;47;32;88;1692;263;88;3.25;52.88;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
317;21192;Drug Development Research;journal;02724391, 10982299;0.582;Q2;62;109;190;5758;567;181;3.23;52.83;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q2)
318;26512;Tetrahedron;journal;14645416, 00404020;0.581;Q2;226;463;2360;26147;5325;2347;2.29;56.47;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
319;23039;Journal of Liposome Research;journal;08982104, 15322394;0.579;Q2;53;37;107;1966;335;105;3.24;53.14;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
320;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;0.579;Q2;144;30;134;1138;341;123;1.58;37.93;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Genetics (clinical) (Q4)"
321;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;0.578;Q3;33;20;74;945;192;73;2.27;47.25;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
322;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.576;Q2;29;13;47;1511;134;45;3.12;116.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3)"
323;16533;Phytochemical Analysis;journal;09580344, 10991565;0.574;Q2;76;85;201;3302;584;198;2.96;38.85;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
324;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.573;Q3;39;72;246;2603;541;238;2.16;36.15;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
325;25106;Human and Experimental Toxicology;journal;09603271;0.572;Q3;82;149;383;7315;1086;374;2.98;49.09;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
326;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.569;Q2;46;184;400;2177;430;339;1.09;11.83;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2)"
327;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.569;Q3;40;46;126;2739;369;124;3.36;59.54;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
328;19700188217;Bioanalysis;journal;17576180, 17576199;0.566;Q2;62;163;593;4671;982;514;1.65;28.66;United Kingdom;Western Europe;Future Science;2009-2021;"Analytical Chemistry (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
329;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.565;Q2;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
330;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.563;Q3;53;70;234;2599;489;191;2.13;37.13;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
331;22319;Toxicon;journal;18793150, 00410101;0.561;Q3;133;254;719;13087;1876;703;2.76;51.52;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q3)
332;15840;Journal of Antibiotics;journal;00218820, 18811469;0.56;Q3;84;121;466;4022;1243;436;2.27;33.24;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
333;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.559;Q3;87;113;496;4879;1064;488;2.01;43.18;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q3); Physiology (medical) (Q3)"
334;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.558;Q2;80;80;536;72;1445;532;2.9;0.9;United States;Northern America;American Scientific Publishers;2007-2020;"Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Medicine (miscellaneous) (Q3)"
335;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.557;Q3;52;79;256;2110;182;244;0.72;26.71;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Statistics and Probability (Q3)"
336;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.556;Q3;24;41;141;2008;453;138;3.38;48.98;Germany;Western Europe;Elsevier GmbH;2014-2021;"Plant Science (Q2); Drug Discovery (Q3)"
337;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.555;Q2;88;163;380;9658;888;356;2.41;59.25;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q2); Pharmaceutical Science (Q2)"
338;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.555;Q3;15;55;34;3286;115;34;2.24;59.75;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
339;21100239265;PharmaNutrition;journal;22134344;0.548;Q3;23;57;68;4231;237;68;2.1;74.23;Netherlands;Western Europe;Elsevier BV;2013-2021;"Food Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
340;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;0.546;Q3;18;22;103;740;241;102;1.67;33.64;South Korea;Asiatic Region;Korean Pharmacopuncture Institute;2016-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
341;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.545;Q3;70;0;83;0;217;83;0;0;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Pathology and Forensic Medicine (Q2); Medicine (miscellaneous) (Q3); Toxicology (Q3); Cell Biology (Q4)"
342;27210;In Vivo;journal;17917549, 0258851X;0.545;Q3;64;491;720;14995;1554;720;2.07;30.54;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
343;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.543;Q3;76;258;779;9010;1627;768;2.1;34.92;United States;Northern America;Springer New York;1966-2021;"Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q3)"
344;24578;Mathematical Medicine and Biology;journal;14778599;0.542;Q3;46;22;73;1002;112;73;1.71;45.55;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Modeling and Simulation (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
345;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;0.541;Q3;12;14;60;491;130;53;2.16;35.07;United States;Northern America;Mary Ann Liebert Inc.;2015-2021;"Medical Laboratory Technology (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
346;21167;Pharmacogenomics;journal;14622416, 17448042;0.541;Q3;94;120;424;5591;838;405;1.82;46.59;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Genetics (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
347;26514;Tetrahedron Letters;journal;00404039, 18733581;0.541;Q3;173;791;2803;30585;6044;2803;2.27;38.67;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Organic Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3)"
348;20570;Chemotherapy;journal;00093157, 14219794;0.539;Q3;58;29;116;882;228;109;2.2;30.41;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
349;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.538;Q2;63;169;522;5059;912;488;1.63;29.93;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
350;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.534;Q3;52;63;145;1392;273;117;1.44;22.1;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
351;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.532;Q2;66;73;219;2541;497;215;2.53;34.81;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
352;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.53;Q3;25;32;37;992;69;37;1.42;31;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q3)"
353;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.527;Q3;62;81;315;2752;436;311;1.38;33.98;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q2); Pharmacology (Q3)"
354;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.526;Q3;62;177;416;8642;1399;410;3.53;48.82;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
355;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.517;Q2;81;51;189;2323;562;189;2.82;45.55;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Bioengineering (Q3); Colloid and Surface Chemistry (Q3)"
356;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.515;Q3;52;67;185;2463;304;179;1.52;36.76;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.514;Q3;33;56;205;2231;360;204;1.72;39.84;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q3); Physiology (Q3)"
358;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.512;Q2;50;89;299;2329;653;279;2.18;26.17;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
359;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.512;Q2;46;57;121;2933;424;121;3.42;51.46;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
360;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.512;Q3;62;101;248;3957;579;237;2.05;39.18;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
361;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.511;Q2;62;127;386;6090;1000;369;2.5;47.95;United States;Northern America;Informa Healthcare;1996-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3)"
362;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.51;Q3;32;49;113;2863;357;110;2.62;58.43;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q2); Infectious Diseases (Q3); Parasitology (Q3); Toxicology (Q3)"
363;21194;Pharmacology;journal;00317012, 14230313;0.51;Q3;60;80;241;2965;447;235;1.78;37.06;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
364;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.509;Q3;32;44;130;1867;182;115;1.39;42.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
365;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.508;Q3;100;231;590;14800;1385;572;2.23;64.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Molecular Medicine (Q3); Pharmacology (Q3); Cancer Research (Q4)"
366;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.507;Q3;50;389;753;18960;1824;747;2.48;48.74;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
367;13671;Biologicals;journal;10958320, 10451056;0.503;Q3;60;76;238;2236;437;233;1.77;29.42;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
368;21100793213;Current Pharmacology Reports;journal;2198641X;0.503;Q3;26;40;123;3327;213;121;1.52;83.18;Switzerland;Western Europe;Springer International Publishing AG;2015-2021;"Biochemistry (Q3); Drug Discovery (Q3); Genetics (Q3); Pharmacology (Q3)"
369;19300156901;Dose-Response;journal;15593258;0.502;Q3;41;192;268;7831;664;228;2.3;40.79;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
370;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.497;Q2;81;38;151;1882;305;151;1.83;49.53;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
371;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.493;Q3;46;71;227;3605;599;226;2.79;50.77;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
372;4500151530;Personalized Medicine;journal;17410541;0.489;Q3;33;38;192;2033;320;157;1.44;53.5;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
373;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.487;Q3;99;351;1082;5269;1324;865;1.24;15.01;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Pharmacy (Q1); Health Policy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
374;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.486;Q3;80;49;179;1149;278;165;1.3;23.45;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
375;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.486;Q2;13;37;55;1838;124;50;2.58;49.68;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
376;19900192900;Molecular Informatics;journal;18681751, 18681743;0.481;Q3;70;67;196;2810;497;185;2.75;41.94;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
377;25898;Journal of Peptide Science;journal;10752617, 10991387;0.475;Q3;68;47;242;1900;457;237;1.7;40.43;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Biochemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Biology (Q4); Structural Biology (Q4)"
378;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.471;Q3;33;110;307;3926;614;305;1.9;35.69;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
379;14805;Steroids;journal;0039128X, 18785867;0.469;Q3;107;141;438;6408;1016;433;2.48;45.45;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q3); Clinical Biochemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Endocrinology (Q4); Molecular Biology (Q4)"
380;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.468;Q2;65;116;264;6259;796;261;3.29;53.96;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
381;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.468;Q3;74;96;312;5625;641;310;2.09;58.59;United States;Northern America;Wiley-Blackwell;1986-2021;"Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
382;145693;Canadian Pharmacists Journal;journal;17151635;0.468;Q2;24;71;190;1174;262;110;1.41;16.54;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
383;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.466;Q2;35;177;434;3097;459;245;0.84;17.5;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
384;14822;Xenobiotica;journal;00498254, 13665928;0.465;Q3;82;164;416;6765;709;416;1.59;41.25;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Toxicology (Q3)"
385;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.45;Q3;50;49;166;2590;401;166;2.57;52.86;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Bioengineering (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
386;21100873055;Cosmetics;journal;20799284;0.449;Q2;27;96;199;4874;560;190;2.74;50.77;Switzerland;Western Europe;MDPI AG;2014-2021;"Chemical Engineering (miscellaneous) (Q2); Pharmaceutical Science (Q2); Dermatology (Q3); Surgery (Q3); Aging (Q4)"
387;130025;Current Drug Delivery;journal;15672018;0.449;Q2;65;76;319;5298;724;302;2.49;69.71;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
388;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.449;Q3;28;10;66;268;104;66;1.26;26.8;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
389;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.449;Q3;42;43;71;1512;139;63;1.58;35.16;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
390;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.448;Q3;37;41;116;2171;258;112;1.9;52.95;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
391;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.44;Q3;21;0;8;0;10;7;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
392;21100470510;Drug Research;journal;21949379, 21949387;0.433;Q3;65;89;327;2254;597;290;1.82;25.33;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
393;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.432;Q3;62;61;182;2707;272;157;1.69;44.38;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
394;23412;Journal of AOAC International;journal;10603271;0.432;Q3;90;96;740;2706;1108;714;1.55;28.19;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Food Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3); Pharmacology (Q3)"
395;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.432;Q3;48;57;276;1876;403;267;1.61;32.91;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
396;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.432;Q2;50;78;321;2404;725;321;2.09;30.82;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
397;16948;Chirality;journal;1520636X, 08990042;0.43;Q3;80;130;322;5093;700;319;2.24;39.18;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q3); Catalysis (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Spectroscopy (Q3)"
398;17500155003;Records of Natural Products;journal;13076167;0.43;Q3;33;49;216;1263;383;215;1.78;25.78;Turkey;Middle East;ACG Publications;2009-2022;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
399;35190;Revista Espanola de Quimioterapia;journal;02143429;0.43;Q3;26;79;337;2051;316;232;0.96;25.96;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
400;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.422;Q3;14;0;112;0;161;107;1.54;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q2); Environmental Science (miscellaneous) (Q2); Toxicology (Q3)"
401;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.422;Q3;46;162;210;8001;474;207;2.42;49.39;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
402;21744;Planta Medica;journal;14390221, 00320943;0.422;Q2;122;134;462;5830;1356;443;3.08;43.51;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
403;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.42;Q2;39;90;228;2738;301;194;1.31;30.42;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
404;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.419;Q2;61;27;134;1409;235;131;1.67;52.19;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
405;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.418;Q3;53;59;164;2543;303;162;2.03;43.1;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
406;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.415;Q3;40;17;49;759;92;43;1.83;44.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
407;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.414;Q3;36;115;235;4708;395;228;1.61;40.94;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
408;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.413;Q2;40;58;165;163;129;145;0.77;2.81;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
409;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.404;Q2;27;1;59;0;88;59;1.17;0;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
410;21100896682;Toxicon: X;journal;25901710;0.404;Q4;8;44;17;2880;40;17;2.35;65.45;United Kingdom;Western Europe;Elsevier Ltd.;2019-2021;Toxicology (Q4)
411;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.403;Q3;19;39;103;1240;112;97;1.07;31.79;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
412;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.402;Q3;58;44;122;1257;160;110;1.37;28.57;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
413;130089;Toxin Reviews;journal;15569543, 15569551;0.402;Q4;46;75;128;4551;344;124;2.51;60.68;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
414;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.401;Q2;60;38;127;1268;279;127;2.3;33.37;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
415;23942;Biomedical Chromatography;journal;10990801, 02693879;0.4;Q3;68;262;840;8058;1406;835;1.66;30.76;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
416;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.399;Q2;31;67;249;1878;402;234;1.6;28.03;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Clinical Psychology (Q3); Medicine (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4)"
417;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.395;Q2;21;79;207;2841;263;197;1.14;35.96;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
418;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.393;Q3;95;161;528;6152;832;515;1.61;38.21;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
419;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;0.387;Q3;12;43;116;4041;148;92;1.37;93.98;United Kingdom;Western Europe;Taylor and Francis Ltd.;2016-2021;"Drug Discovery (Q3); Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
420;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.385;Q3;26;16;162;462;196;135;0.8;28.88;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
421;29053;Molecular Diversity;journal;1573501X, 13811991;0.385;Q3;58;96;228;5047;494;227;2.37;52.57;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Information Systems (Q2); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
422;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.382;Q2;31;70;98;3572;193;96;2.06;51.03;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
423;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.375;Q3;29;97;167;3356;299;140;1.29;34.6;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
424;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.373;Q3;12;34;113;4308;70;6;0.64;126.71;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
425;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.37;Q2;48;168;604;6572;1123;598;1.7;39.12;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
426;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.365;Q3;42;41;86;1604;134;81;1.53;39.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
427;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.363;Q3;69;103;297;2169;308;281;1.03;21.06;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
428;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.362;Q4;32;61;200;2071;326;197;1.64;33.95;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
429;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.361;Q4;64;59;146;1949;182;128;1.09;33.03;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
430;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.358;Q2;42;139;423;2716;597;393;1.34;19.54;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
431;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.353;Q3;75;69;220;2745;439;217;1.72;39.78;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q3); Toxicology (Q4)"
432;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.352;Q2;50;182;712;8210;1357;712;1.84;45.11;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
433;21717;Die Pharmazie;journal;00317144;0.351;Q2;66;129;407;3980;555;407;1.16;30.85;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
434;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.349;Q3;63;183;551;1505;469;250;0.71;8.22;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
435;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.346;Q2;36;46;80;1757;126;75;1.75;38.2;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
436;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.342;Q3;36;20;72;1241;116;66;1.8;62.05;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
437;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.341;Q3;13;48;127;2281;214;126;1.94;47.52;Iran;Middle East;Nickan Research Institute;2015-2021;Drug Discovery (Q3)
438;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.341;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
439;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.339;Q4;9;44;125;1338;84;114;0.56;30.41;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
440;5800173386;Current Drug Safety;journal;15748863;0.334;Q3;37;36;117;1064;145;114;1.41;29.56;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
441;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.325;Q3;38;40;99;888;196;89;1.79;22.2;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q3)
442;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.322;Q3;55;122;116;4449;159;112;1.4;36.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
443;79053;Natural Product Sciences;journal;12263907;0.322;Q3;28;44;143;1563;218;143;1.63;35.52;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
444;130047;Current Drug Discovery Technologies;journal;15701638;0.319;Q3;44;70;105;4231;173;101;1.67;60.44;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q3)
445;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.312;Q2;23;48;150;1705;199;150;1.03;35.52;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
446;21100841779;ADMET and DMPK;journal;18487718;0.309;Q2;15;24;66;1500;87;61;1.32;62.5;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Health (social science) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
447;22338;Hospital Pharmacy;journal;19451253, 00185787;0.309;Q3;24;80;261;2070;255;220;0.79;25.88;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
448;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.308;Q3;46;92;242;4815;557;238;2.19;52.34;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
449;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.306;Q2;33;18;119;632;197;119;1.81;35.11;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
450;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.304;Q4;61;39;90;0;62;64;0.67;0;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
451;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.304;Q3;38;243;268;11829;399;268;1.5;48.68;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Drug Discovery (Q3); Biochemistry (Q4); Bioengineering (Q4); Molecular Medicine (Q4)"
452;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.302;Q3;28;0;53;0;57;45;1.26;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
453;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.301;Q3;51;90;324;3925;427;322;1.21;43.61;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Analytical Chemistry (Q3); Pharmaceutical Science (Q3); Biochemistry (Q4); Clinical Biochemistry (Q4)"
454;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.301;Q3;37;34;96;588;79;80;0.53;17.29;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
455;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.3;Q2;23;0;15;0;25;15;0;0;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
456;18800156720;Dissolution Technologies;journal;1521298X;0.298;Q3;34;20;74;529;63;62;0.83;26.45;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q3)
457;19700174889;Drug Target Insights;journal;11773928;0.297;Q2;13;5;10;283;22;9;2.29;56.6;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
458;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.297;Q3;34;6;74;725;92;74;1.02;120.83;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
459;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.296;Q3;24;34;39;1670;62;36;1.5;49.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
460;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.294;Q3;18;12;33;758;62;31;1.56;63.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
461;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.292;Q3;66;109;272;4931;365;251;1.16;45.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q4)"
462;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.286;Q3;62;82;201;2027;238;182;1;24.72;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
463;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.286;Q2;41;217;896;8547;1231;891;1.36;39.39;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
464;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.285;Q3;30;25;106;1660;65;106;0.71;66.4;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
465;4700152612;Current Nanoscience;journal;15734137;0.285;Q3;47;87;212;6470;342;203;1.71;74.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Nanoscience and Nanotechnology (Q4)"
466;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.281;Q2;24;327;717;9125;867;717;1.25;27.91;India;Asiatic Region;Rasayan Journal;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
467;21810;Farmacia;journal;00148237;0.278;Q2;27;150;447;5468;552;447;1.37;36.45;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
468;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.273;Q3;27;58;152;1611;118;148;0.59;27.78;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
469;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.272;Q4;17;40;123;1692;136;122;1.21;42.3;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
470;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.271;Q3;10;0;2;0;6;2;3;0;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
471;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.27;Q2;43;153;359;5156;528;357;1.55;33.7;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
472;5800173401;Current Bioactive Compounds;journal;15734072;0.269;Q2;27;133;162;6765;245;156;1.31;50.86;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
473;144963;Drug Discovery Today: Disease Models;journal;17406757;0.268;Q4;28;23;55;1686;42;49;0.93;73.3;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
474;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.268;Q3;42;201;295;4865;592;292;1.52;24.2;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Bioengineering (Q4)"
475;19700175096;Pharmacognosy Journal;journal;09753575;0.268;Q3;25;242;616;7806;740;616;1.06;32.26;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
476;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.264;Q3;19;24;37;969;34;33;1.19;40.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
477;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.256;Q3;14;30;105;1431;87;94;0.37;47.7;Italy;Western Europe;ASLERD;2012-2021;"Architecture (Q2); Media Technology (Q2); Computer Science Applications (Q3); Human-Computer Interaction (Q3); Pharmacology (Q3); Social Sciences (miscellaneous) (Q3)"
478;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.254;Q4;48;37;128;1319;136;116;1;35.65;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
479;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.247;Q4;51;196;496;7289;404;489;0.75;37.19;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
480;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.247;Q3;17;0;58;0;53;47;1.29;0;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
481;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.246;Q3;20;100;321;531;136;179;0.54;5.31;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
482;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.245;Q3;61;293;411;7711;490;409;1.1;26.32;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q3)
483;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.244;Q3;16;56;154;1734;117;142;0.83;30.96;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Pharmacy (Q2); Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
484;25864;Heterocycles;journal;03855414;0.242;Q3;66;168;656;5386;424;651;0.69;32.06;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Pharmacology (Q3); Analytical Chemistry (Q4); Organic Chemistry (Q4)"
485;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;0.241;Q4;13;41;117;1611;123;117;1.22;39.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous) (Q3); Complementary and Alternative Medicine (Q3); Plant Science (Q3); Drug Discovery (Q4); Pharmacology (Q4); Toxicology (Q4)"
486;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.241;Q3;16;97;167;3281;181;167;0.93;33.82;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
487;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.238;Q4;10;46;115;1158;77;115;0.66;25.17;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Veterinary (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4)"
488;21100909468;Environmental Health and Toxicology;journal;22336567;0.238;Q4;5;22;22;1041;26;19;1.18;47.32;South Korea;Asiatic Region;Korean Society of Environmental Health and Toxicology;2018-2021;"Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
489;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.238;Q4;24;72;194;760;118;151;0.53;10.56;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
490;21100924991;Frontiers in Clinical Drug Research - Alzheimer Disorders;book series;22145168, 24518743;0.238;Q3;2;0;7;0;5;1;0.71;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3); Neurology (clinical) (Q4)"
491;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.238;Q3;20;273;840;8860;713;840;0.84;32.45;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q3)
492;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.238;Q3;19;69;146;2824;199;140;0.89;40.93;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
493;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.237;Q3;22;49;228;4388;161;216;0.65;89.55;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2021;"Health Policy (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
494;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.236;Q3;16;8;34;141;19;22;0.65;17.63;United States;Northern America;IPEC-Americas;2010-2021;"Food Science (Q3); Pharmaceutical Science (Q3)"
495;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.234;Q3;6;14;39;322;22;32;0.65;23;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
496;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.228;Q3;24;29;167;926;138;163;0.75;31.93;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
497;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.226;Q4;31;73;112;3171;125;100;1.31;43.44;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q4); Medicine (miscellaneous) (Q4); Molecular Medicine (Q4)"
498;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.225;Q3;47;853;2555;24884;3158;2555;1.26;29.17;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
499;130038;Letters in Drug Design and Discovery;journal;15701808;0.223;Q3;35;143;426;5765;462;413;1.11;40.31;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
500;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.223;Q3;12;6;19;207;10;19;0.36;34.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
501;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.223;Q3;42;351;1184;7730;840;1184;0.64;22.02;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q3)
502;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.221;Q4;50;298;1227;10937;1116;1205;0.94;36.7;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Plant Science (Q4)"
503;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.22;Q4;17;79;214;1989;179;191;0.63;25.18;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Infectious Diseases (Q4); Microbiology (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
504;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.218;Q4;22;45;125;2812;124;125;0.99;62.49;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
505;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.215;Q3;20;32;97;909;105;86;0.95;28.41;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
506;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.214;Q4;5;27;53;895;8;53;0.21;33.15;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
507;21100928216;Journal of Research in Pharmacy;journal;26306344;0.214;Q3;16;94;275;3359;272;273;0.87;35.73;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
508;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.213;Q3;3;0;4;0;4;4;0;0;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
509;21100904334;Natural Volatiles and Essential Oils (discontinued);journal;21489637;0.212;Q3;4;21;31;703;20;31;0.65;33.48;Turkey;Middle East;Badebio Biotechnololgy Ltd;2018-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Plant Science (Q4)"
510;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.21;Q3;25;137;241;5109;204;239;0.85;37.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
511;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.209;Q3;39;356;1041;8189;730;1041;0.57;23;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
512;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.208;Q4;8;165;269;5405;139;269;0.57;32.76;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
513;21100972595;Iranian Journal of Toxicology;journal;22519459, 20082967;0.208;Q4;3;32;1;1001;12;1;12;31.28;Iran;Middle East;Arak University of Medical Sciences;2019-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
514;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.206;Q4;29;35;98;1201;96;98;0.83;34.31;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
515;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.205;Q3;10;0;28;0;18;28;0.75;0;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
516;21100941292;Frontiers in Clinical Drug Research - Anti Infectives;book series;24523208, 23523212;0.205;Q4;1;7;7;778;3;2;0.43;111.14;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019-2020;"Pharmacology (medical) (Q3); Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4)"
517;21100451405;Natural Products Journal;journal;22103163, 22103155;0.205;Q4;13;73;107;2957;82;104;1;40.51;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
518;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.204;Q3;10;51;125;1789;93;121;0.74;35.08;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
519;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.201;Q3;22;210;483;6635;399;482;0.76;31.6;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
520;21823;Pharmacia;journal;04280296;0.201;Q3;16;57;85;1621;97;85;0.95;28.44;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
521;19700181241;Physiology and Pharmacology;journal;17350581;0.2;Q4;12;34;106;1631;70;104;0.6;47.97;Iran;Middle East;Neuroscience Research Center;2009-2021;"Linguistics and Language (Q2); Pharmacology (Q4); Physiology (Q4)"
522;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.198;Q3;13;38;104;847;69;95;0.46;22.29;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
523;21211;Pharmacy Education;journal;14772701, 15602214;0.198;Q3;18;36;108;1091;59;108;0.5;30.31;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
524;15600154705;EnvironmentAsia;journal;19061714;0.195;Q4;19;46;152;1274;86;152;0.55;27.7;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
525;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.194;Q4;9;83;197;1977;58;194;0.33;23.82;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
526;58808;Pharmaceutical Care and Research;journal;16712838;0.192;Q3;8;124;395;1439;38;393;0.08;11.6;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
527;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.191;Q4;22;242;775;7524;638;775;0.9;31.09;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
528;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.191;Q4;34;212;584;5202;374;581;0.63;24.54;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
529;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.19;Q3;15;0;32;0;11;23;0.17;0;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Decision Sciences (miscellaneous) (Q4)"
530;21100208082;VacciMonitor;journal;10250298, 1025028X;0.19;Q4;5;20;44;415;13;43;0.32;20.75;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
531;21100248874;Dilemas;journal;19835922, 21782792;0.187;Q3;9;41;95;1547;17;93;0.18;37.73;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2021;"Law (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3); Sociology and Political Science (Q3)"
532;21758;Prescrire International;journal;11677422;0.186;Q4;13;77;204;850;25;157;0.14;11.04;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
533;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;24;29;234;288;53;203;0.21;9.93;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
534;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.178;Q4;24;47;55;1753;36;51;0.73;37.3;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q4); Pharmacology (Q4)"
535;21101016799;Farmakoekonomika;journal;20704933, 20704909;0.177;Q4;6;42;38;1074;20;38;0.53;25.57;Russian Federation;Eastern Europe;IRBIS LLC;2019-2021;"Health Policy (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
536;21100943519;Accounting (discontinued);journal;23697407, 23697393;0.175;Q3;10;160;21;5349;37;21;1.76;33.43;Canada;Northern America;Growing Science;2018-2021;"Pharmaceutical Science (Q3); Accounting (Q4)"
537;5800173394;Current Drug Therapy;journal;15748855;0.174;Q3;17;53;51;3296;30;49;0.54;62.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
538;21100903428;Drug Delivery Letters;journal;2210304X, 22103031;0.174;Q3;5;31;33;1566;21;32;0.64;50.52;Netherlands;Western Europe;Bentham Science Publishers B.V.;2018-2021;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
539;21100922188;Farmatsiya i Farmakologiya;journal;23079266, 24132241;0.174;Q3;5;28;35;959;31;35;0.89;34.25;Russian Federation;Eastern Europe;Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute;2019-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
540;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.173;-;12;66;86;2268;62;86;0.49;34.36;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q3)
541;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.172;Q3;32;763;2249;26379;1080;2249;0.45;34.57;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
542;110097;Food and Drug Law Journal;journal;1064590X;0.171;Q4;22;0;43;0;33;42;0.84;0;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
543;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.171;Q3;10;39;34;1315;23;34;0.7;33.72;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q3)
544;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.17;Q3;45;81;469;2731;248;468;0.28;33.72;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
545;22908;Chinese Pharmacological Bulletin;journal;10011978;0.169;Q4;17;111;1023;1965;229;1022;0.24;17.7;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
546;18633;Herba Polonica;journal;00180599;0.169;Q4;6;27;49;997;39;49;0.8;36.93;Poland;Eastern Europe;Instytut Roslin i Przetworow Zielarskich;1973-1979, 2018-2021;"Complementary and Alternative Medicine (Q3); Ecology, Evolution, Behavior and Systematics (Q4); Pharmacology (Q4); Plant Science (Q4)"
547;80593;Journal of Medicinal Plants;journal;16840240;0.168;Q4;23;96;191;3517;89;190;0.44;36.64;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
548;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.167;Q3;12;36;90;1240;53;90;0.63;34.44;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
549;20826;Military Medical Science Letters (Vojenske Zdravotnicke Listy);journal;03727025, 2571113X;0.164;Q3;4;25;55;850;12;43;0.22;34;Czech Republic;Eastern Europe;Vojenska Lekarska Akademie;1948-1951, 1961, 1963, 1965, 1973-1992, 2018-2021;"Emergency Medical Services (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Emergency Medicine (Q4); Immunology and Microbiology (miscellaneous)  (Q4); Public Health, Environmental and Occupational Health (Q4); Veterinary (miscellaneous) (Q4)"
550;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.163;Q4;38;5;75;116;44;75;0.46;23.2;United States;Northern America;Old City Publishing;1996, 2002-2020;"Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4)"
551;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;0.162;Q3;8;101;286;2651;122;286;0.33;26.25;India;Asiatic Region;"Society of Pharmaceutical Education &amp; Research [SPER]";2015, 2017-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
552;20564;Ceska a Slovenska Farmacie;journal;12107816;0.159;Q3;17;31;85;1090;48;84;0.65;35.16;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
553;4700152607;Current Enzyme Inhibition;journal;15734080;0.157;Q4;18;24;61;1475;27;56;0.4;61.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
554;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.157;Q4;14;0;25;0;15;23;1;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
555;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.155;Q4;53;67;179;1578;52;165;0.25;23.55;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q4); Physiology (Q4); Physiology (medical) (Q4)"
556;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.155;Q3;9;35;100;1542;56;100;0.58;44.06;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
557;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.154;Q4;22;31;61;1063;30;61;0.56;34.29;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
558;19700170837;Vitae;journal;21452660, 01214004;0.154;Q3;15;10;45;462;23;37;0.37;46.2;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
559;21100867470;Indonesian Journal of Pharmacy;journal;23389486, 23389427;0.153;Q3;7;39;98;1228;62;98;0.57;31.49;Indonesia;Asiatic Region;Universitas Gadjah Mada - Faculty of Pharmacy;2016-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (medical) (Q4)"
560;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.152;Q3;17;23;61;760;16;51;0.21;33.04;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
561;22881;Yaoxue Xuebao;journal;05134870;0.152;Q3;34;340;770;15048;377;770;0.5;44.26;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
562;21100804474;European Pharmaceutical Journal;journal;24536725;0.151;Q3;8;17;35;440;17;35;0.1;25.88;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
563;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.15;Q3;18;27;71;1325;31;71;0.47;49.07;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q3)
564;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.15;Q3;48;86;82;2915;64;81;0.75;33.9;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
565;22934;Chinese Pharmaceutical Journal;journal;10012494;0.149;Q3;21;325;1046;7585;288;1046;0.28;23.34;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
566;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.149;Q3;14;79;102;2376;43;102;0.48;30.08;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
567;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.144;Q3;11;37;46;1465;14;46;0.23;39.59;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
568;21100858119;Pharmaceutical Sciences Asia;journal;25868195, 25868470;0.144;Q3;4;47;80;1303;33;80;0.41;27.72;Thailand;Asiatic Region;Mahidol University - Faculty of Pharmacy;2017-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
569;24097;Journal of the Indian Chemical Society;journal;00194522;0.142;Q4;33;178;335;4830;121;335;0.45;27.13;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
570;130170;Phytotherapie;journal;17652847, 16248597;0.142;Q4;18;49;213;1718;60;189;0.19;35.06;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
571;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.142;Q3;9;34;96;823;7;85;0.14;24.21;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
572;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.141;Q4;12;43;95;2190;43;95;0.39;50.93;Canada;Northern America;;2011-2021;"Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
573;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.141;Q3;43;194;634;4177;189;530;0.28;21.53;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
574;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.14;Q4;17;746;2481;24089;704;2481;0.26;32.29;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
575;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.14;Q4;13;38;81;1045;27;81;0.31;27.5;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
576;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.14;Q4;14;18;43;0;16;43;0.22;0;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
577;21798;Farmaceutski Glasnik;journal;00148202;0.139;Q4;6;63;243;970;6;208;0.02;15.4;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
578;23171;Korean Journal of Pharmacognosy;journal;02533073;0.139;Q4;17;45;144;1314;39;144;0.27;29.2;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
579;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.138;Q4;13;96;275;2640;77;274;0.33;27.5;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q4)
580;13000154717;Current Topics in Toxicology;journal;09728228;0.137;Q4;7;23;29;819;9;29;0.29;35.61;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
581;9100153105;Current Topics in Pharmacology;journal;09724559;0.135;Q4;6;14;35;591;8;35;0.26;42.21;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
582;21100967064;Defence Life Science Journal;journal;24560537;0.135;Q4;3;43;37;1473;16;36;0.43;34.26;India;Asiatic Region;"Defence Scientific Information &amp; Documentation Centre (DESIDOC)";2019-2021;"Agricultural and Biological Sciences (miscellaneous) (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
583;19700175149;African Journal Biomedical Research;journal;11195096;0.134;Q4;17;93;141;2652;37;136;0.19;28.52;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
584;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.134;Q4;10;40;120;1251;44;120;0.44;31.28;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
585;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.134;Q4;26;2;3;0;1;3;0;0;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Molecular Biology (Q4); Pharmaceutical Science (Q4)"
586;21867;Geneesmiddelenbulletin;journal;03044629;0.133;Q4;7;24;74;607;7;64;0.12;25.29;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
587;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.133;Q4;10;104;184;2634;79;184;0.47;25.33;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q4)
588;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;0.133;Q4;26;349;1064;8634;256;1064;0.23;24.74;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
589;21101005186;Research Results in Pharmacology;journal;2658381X;0.132;Q4;8;44;77;1610;93;76;1.21;36.59;Russian Federation;Eastern Europe;Belgorod State National Research University;2018-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
590;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.131;Q4;11;74;201;0;62;176;0.36;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
591;19700174658;Regulatory Rapporteur;trade journal;17428955;0.13;Q4;6;75;210;399;12;137;0.04;5.32;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
592;19408;Actualites Pharmaceutiques;journal;05153700;0.129;Q4;5;187;537;1504;26;433;0.03;8.04;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
593;21100936542;Biomedical and Biopharmaceutical Research;journal;21822379, 21822360;0.129;Q4;2;26;21;681;8;20;0.38;26.19;Portugal;Western Europe;ALIES;2019-2021;"Pharmacy (Q3); Food Science (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
594;19700174961;BioProcess International;trade journal;15426319;0.129;Q4;23;0;39;0;8;39;0;0;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Drug Discovery (Q4)"
595;144879;Toxicology International;journal;09716580;0.129;Q4;28;33;69;977;15;69;0.11;29.61;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
596;22358;U.S. Pharmacist;trade journal;01484818;0.129;Q4;9;133;356;1451;56;232;0.16;10.91;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
597;21100829925;HiSTOReLo;journal;2145132X;0.128;Q4;3;24;72;1002;10;61;0.12;41.75;Colombia;Latin America;Universidad Nacional de Colombia;2013-2021;"History (Q2); Cultural Studies (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Social Sciences (miscellaneous) (Q4)"
598;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.128;Q4;10;78;163;2938;37;162;0.27;37.67;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
599;20065;BioPharm International;trade journal;1542166X, 19391862;0.127;Q4;29;101;357;583;38;136;0.03;5.77;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Biotechnology (Q4); Pharmaceutical Science (Q4)"
600;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.127;Q4;16;43;449;841;63;447;0.14;19.56;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
601;21100933230;Tropical Journal of Natural Product Research;journal;26160692, 26160684;0.127;Q4;5;192;204;7285;65;197;0.32;37.94;Nigeria;Africa;Faculty of Pharmacy, University of Benin;2017-2021;"Analytical Chemistry (Q4); Biochemistry (Q4); Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
602;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.126;Q4;27;154;272;4455;68;271;0.23;28.93;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
603;21100932762;Advanced Therapeutics;journal;23663987;0.125;Q4;24;66;155;6879;823;152;5.31;104.23;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2018-2021;"Biochemistry (medical) (Q4); Genetics (clinical) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
604;21100854242;International Nano Letters;journal;22285326, 20089295;0.125;Q4;1;0;1;0;0;1;0;0;United States;Northern America;Springer Science + Business Media;2014, 2019, 2021;"Bioengineering (Q4); Biomedical Engineering (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
605;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.125;Q4;10;47;144;2846;98;1;0.73;60.55;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
606;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.125;Q4;6;72;360;432;14;231;0.03;6;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
607;21100932743;Pharmaceutical Technology in Hospital Pharmacy;journal;2365242X, 23652411;0.125;Q4;0;0;1;0;0;1;0;0;Germany;Western Europe;Walter de Gruyter GmbH;2019-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
608;73076;Drug Discovery World;journal;14694344;0.123;Q4;13;0;52;0;5;51;0.12;0;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
609;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.123;Q4;19;96;291;1537;40;260;0.17;16.01;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
610;17700156303;Neuromethods;book series;19406045, 08932336;0.123;Q4;21;112;503;5808;210;12;0.45;51.86;United States;Northern America;Humana Press;2009-2022;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Neuroscience (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
611;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.123;Q4;13;63;180;760;5;122;0.03;12.06;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
612;21100913634;Iraqi Journal of Pharmaceutical Sciences;journal;16833597, 25213512;0.122;Q4;4;48;54;1784;17;54;0.31;37.17;Iraq;Middle East;University of Baghdad - College of Pharmacy;2018-2021;"Analytical Chemistry (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
613;22375;Indian Drugs;journal;0019462X;0.121;Q4;31;125;373;2935;44;347;0.13;23.48;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
614;22906;Journal of China Pharmaceutical University;journal;10005048;0.121;Q4;14;96;292;2676;53;292;0.19;27.88;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
615;21100878895;10th International Conference on Environmental Pollution and Public Health, EPPH 2018;conference and proceedings;-;0.119;-;2;0;8;0;3;7;0.38;0;China;Asiatic Region;;;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
616;21100905494;Analytical Science and Technology;journal;12250163, 22888985;0.119;Q4;3;31;29;680;3;29;0.1;21.94;South Korea;Asiatic Region;Korea Society of Analytical Science;2019-2021;"Agronomy and Crop Science (Q4); Analytical Chemistry (Q4); Environmental Chemistry (Q4); Food Science (Q4); Materials Chemistry (Q4); Pharmacology (Q4)"
617;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.119;Q4;14;21;113;485;20;111;0.17;23.1;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
618;19700175034;Pharmaceutical Processing;trade journal;10499156;0.118;Q4;3;0;49;0;3;4;0.08;0;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
619;73430;Pharmaceutical Technology;journal;15432521;0.118;Q4;38;141;690;708;65;210;0.08;5.02;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Biophysics (Q4); Pharmaceutical Science (Q4)"
620;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.116;Q4;12;125;319;4353;53;316;0.14;34.82;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
621;21265;Drugs of the Future;journal;03778282;0.115;Q4;45;75;251;2235;31;250;0.13;29.8;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
622;21100944623;Environmental Arsenic in a ChangingWorld - 7th International Congress and Exhibition Arsenic in the Environment, 2018;conference and proceedings;-;0.115;-;2;0;213;0;15;207;0.07;0;United Kingdom;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
623;19700174925;European Pharmaceutical Review;trade journal;13608606;0.115;Q4;8;0;143;0;21;140;0.04;0;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
624;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.115;Q4;12;2568;945;50027;244;945;0.27;19.48;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
625;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.114;Q4;7;85;212;2095;52;211;0.16;24.65;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
626;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.113;Q4;3;8;40;73;8;40;0.3;9.13;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
627;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.113;Q4;6;0;17;0;3;16;0;0;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
628;21100853016;Antibodies;journal;20734468;0.112;Q4;15;1;2;63;4;2;2;63;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4)"
629;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.112;Q4;15;48;277;670;57;277;0.23;13.96;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
630;22514;Japanese Journal of Chemotherapy;journal;13407007;0.112;Q4;12;37;95;757;8;95;0.06;20.46;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
631;19700174922;Chinese Journal of New Drugs;journal;10033734;0.111;Q4;12;453;1516;10120;154;1516;0.11;22.34;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
632;19700171709;Arhiv za Farmaciju;journal;00041963;0.11;Q4;4;25;71;1068;2;71;0.02;42.72;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
633;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.109;Q4;25;0;8;0;2;7;0;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
634;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.108;Q4;19;0;5;0;3;3;0.5;0;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Strategy and Management (Q4)"
635;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.108;Q4;5;33;85;850;4;81;0.05;25.76;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
636;21102;Pharmaceutical Journal;journal;00316873;0.108;Q4;28;0;72;0;2;21;0;0;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
637;19700174940;SA Pharmaceutical Journal;journal;10151362;0.108;Q4;7;56;218;674;17;143;0.07;12.04;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
638;5800207507;Side Effects of Drugs Annual;book series;03786080;0.108;Q4;6;43;148;2116;44;3;0.35;49.21;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
639;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.107;Q4;14;40;70;1069;21;57;0.37;26.73;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q4); Drug Discovery (Q4)"
640;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.107;Q4;10;0;31;0;3;29;0.05;0;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
641;5200152604;Pharma Times;journal;00316849;0.107;Q4;12;83;191;808;8;120;0.05;9.73;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
642;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.106;Q4;5;198;359;6036;17;354;0.05;30.48;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
643;19700175108;Drug Delivery System;journal;18812732, 09135006;0.106;Q4;8;62;188;1075;8;123;0.05;17.34;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
644;21100982469;Frontiers in Clinical Drug Research - Anti Allergy Agents;book series;22146938, 24523194;0.106;Q4;1;1;7;0;0;4;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019-2020;"Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
645;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.106;Q4;7;10;31;460;1;31;0.05;46;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
646;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.106;Q4;7;85;161;1421;12;150;0.1;16.72;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
647;21100847105;2017 International Conference on Environmental Pollution and Public Health, EPPH 2017;conference and proceedings;-;0.105;-;1;0;6;0;1;5;0;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
648;19700174886;Arzneimitteltherapie;journal;07236913;0.105;Q4;6;137;483;1137;7;193;0.02;8.3;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
649;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.105;Q4;4;6;28;148;11;22;0.58;24.67;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
650;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.105;Q4;7;40;108;605;6;105;0.04;15.13;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
651;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.105;Q4;7;117;673;2256;37;673;0.05;19.28;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
652;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.105;Q4;10;12;256;1740;61;36;0.27;145;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q4)
653;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;5;126;363;2651;18;363;0.05;21.04;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
654;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.104;Q4;6;2;16;24;3;10;0.14;12;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
655;21100986051;Cancer Drug Discovery and Development;book series;21969906, 21969914;0.103;Q4;5;14;100;1651;44;7;0.56;117.93;United States;Northern America;Springer New York;2014-2015, 2017-2020;"Cancer Research (Q4); Drug Discovery (Q4); Oncology (Q4)"
656;21101020026;Frontiers in Anti-infective Drug Discovery;book series;1879663X, 24519162;0.103;Q4;1;1;8;141;0;7;0;141;Netherlands;Western Europe;Bentham Science Publishers B.V.;2019-2021;"Drug Discovery (Q4); Infectious Diseases (Q4); Molecular Medicine (Q4)"
657;21100881509;Journal of International Pharmaceutical Research;journal;16740440;0.103;Q4;7;168;187;5236;13;187;0.04;31.17;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science (Q4)
658;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.103;Q4;10;0;9;0;1;9;0;0;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
659;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.102;Q4;11;7;11;135;0;11;0;19.29;India;Asiatic Region;Anil Aggrawal;2000-2020;"Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
660;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.102;Q4;8;24;12;827;0;12;0;34.46;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
661;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.102;Q4;11;74;198;370;7;107;0.05;5;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q4)
662;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.102;Q4;7;0;13;0;0;13;0;0;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
663;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.102;Q4;5;6;27;149;1;27;0;24.83;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
664;21100900318;Pharmaceutical Discovery, Development and Manufacturing Forum 2018 - Core Programming Area at the 2018 AIChE Annual Meeting;conference and proceedings;-;0.102;-;1;0;14;0;0;13;0;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
665;13718;Pharmaceutical Engineering;journal;02738139;0.102;Q4;16;0;96;0;6;54;0.07;0;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q4)
666;21127;Pharmaceutical Technology Europe;journal;01646826;0.102;Q4;18;18;309;122;11;256;0.05;6.78;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
667;19700175580;PharmacoVigilance Review;journal;17526752;0.102;Q4;2;0;20;0;1;15;0.08;0;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
668;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.102;Q4;19;0;567;0;13;539;0.02;0;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q4)
669;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.101;Q4;7;6;20;197;0;17;0;32.83;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
670;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;163;504;48;2;30;0;0.29;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
671;21100202747;GMP Review;trade journal;14764547;0.101;Q4;2;19;43;38;0;23;0;2;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
672;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.101;Q4;48;1;39;50;1;31;0.03;50;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
673;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.101;Q4;11;0;26;0;2;24;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
674;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;9;34;259;0;32;0;28.78;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
675;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.101;Q4;5;10;42;359;2;38;0.05;35.9;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
676;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.101;Q4;18;16;157;617;2;64;0.14;38.56;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
677;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;11;84;118;0;73;0;10.73;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
678;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.1;Q4;4;0;143;0;0;143;0;0;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
679;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.1;Q4;5;0;96;0;0;81;0;0;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
680;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.1;Q4;9;0;100;0;0;98;0;0;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
681;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;82;215;104;0;215;0;1.27;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
682;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;0;53;0;0;53;0;0;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
683;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.1;Q4;6;0;135;0;1;119;0;0;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
684;21142;Pharmaceutisch Weekblad;journal;00316911;0.1;Q4;9;365;1354;0;7;701;0;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
685;21243;Pharmacy Times;trade journal;00030627;0.1;Q4;8;250;537;1180;2;104;0.01;4.72;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
686;21716;Pharmazeutische Zeitung;journal;00317136;0.1;Q4;7;905;2371;285;2;1107;0;0.31;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
687;20572;PZ Prisma;journal;09455566;0.1;Q4;5;35;102;691;0;90;0;19.74;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
688;21101023830;Acta Marisiensis - Seria Medica;journal;26687763, 22476113;;-;1;28;0;660;0;0;0;23.57;Poland;Eastern Europe;Sciendo;2020-2021;"Dentistry (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
689;21101028570;Advances in Pharmacological and Pharmaceutical Sciences;journal;26334682, 26334690;;-;3;26;0;1216;0;0;0;46.77;United Kingdom;Western Europe;Hindawi Limited;2020-2021;"Biochemistry; Organic Chemistry; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
690;21101018620;Adverse Drug Reactions Journal;journal;10085734;;-;2;193;0;2785;0;0;0;14.43;China;Asiatic Region;Chinese Medical Journals Publishing House Co.Ltd;2020-2021;"Pharmacology; Pharmacology (medical)"
691;21101044928;Beni-Suef University Journal of Basic and Applied Sciences;journal;23148543, 23148535;;-;7;63;25;2822;15;25;0.6;44.79;Germany;Western Europe;Springer Science and Business Media Deutschland GmbH;2019-2021;"Agricultural and Biological Sciences (miscellaneous); Medicine (miscellaneous); Pharmaceutical Science"
692;21100981214;Bioengineering and Translational Medicine;journal;23806761;;-;10;33;0;1751;0;0;0;53.06;United States;Northern America;"John Wiley &amp; Sons Inc.";2020-2021;"Biomedical Engineering; Biotechnology; Pharmaceutical Science"
693;21101021640;Chinese Herbal Medicines;journal;16746384;;-;14;14;1;483;0;1;0;34.5;Netherlands;Western Europe;Elsevier BV;2012, 2016, 2018-2021;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical)"
694;21101039478;Current Research in Toxicology;journal;2666027X;;-;5;19;0;1068;0;0;0;56.21;Netherlands;Western Europe;Elsevier BV;2020-2021;"Applied Microbiology and Biotechnology; Health, Toxicology and Mutagenesis; Toxicology"
695;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;28;95;1263;200;89;2.37;45.11;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
696;21100854828;Current Traditional Medicine;journal;22150846, 22150838;;-;4;30;2;2017;2;1;0;67.23;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2017, 2020-2021;"Complementary and Alternative Medicine; Drug Discovery"
697;21101012656;Drug Development and Registration;journal;26585049, 23052066;;-;3;75;0;1331;0;0;0;17.75;Russian Federation;Eastern Europe;Center of Pharmaceutical Analytics;2020-2021;"Drug Discovery; Pharmaceutical Science"
698;21100202909;Drug Invention Today (discontinued);journal;09757619;;-;20;411;2051;9044;691;2051;0.33;22;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery
699;21101039763;EJNMMI Radiopharmacy and Chemistry;journal;2365421X;;-;6;12;10;507;22;2;0.75;42.25;Switzerland;Western Europe;Springer Science and Business Media Deutschland GmbH;2017-2021;"Analytical Chemistry; Pharmacology; Pharmacology (medical); Radiology, Nuclear Medicine and Imaging"
700;21101047912;Forensic Science and Technology;journal;10083650;;-;2;124;0;1587;0;0;0;12.8;China;Asiatic Region;Editorial Office of Forensic Science and Technology;2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Law; Pathology and Forensic Medicine; Toxicology"
701;21101017910;International Journal of Medical Toxicology and Forensic Medicine;journal;22518770, 22518762;;-;2;60;0;1378;0;0;0;22.97;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2019-2021;"Pathology and Forensic Medicine; Toxicology"
702;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;;-;24;2577;984;73414;707;983;0.74;28.49;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
703;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;;-;39;2;254;113;286;253;0.81;56.5;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology
704;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;;-;21;1664;919;36989;542;918;0.62;22.23;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
705;21101039768;JACCP Journal of the American College of Clinical Pharmacy;journal;25749870;;-;11;142;125;4383;98;99;0.78;30.87;United States;Northern America;Wiley-Blackwell Publishing Ltd;2018-2021;"Pharmaceutical Science; Pharmacology (medical); Pharmacy"
706;21101022494;Journal of Cardiovascular Development and Disease;journal;23083425;;-;21;59;123;4208;413;119;3.45;71.32;Switzerland;Western Europe;MDPI AG;2014-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
707;21101030820;Journal of Chemical Metrology;journal;13076183;;-;3;20;0;534;0;0;0;26.7;Turkey;Middle East;ACG Publications;2020-2021;"Analytical Chemistry; Electrochemistry; Spectroscopy; Toxicology"
708;21100920227;Journal of Critical Reviews (discontinued);journal;23945125;;-;15;2906;131;65194;165;131;1.26;22.43;India;Asiatic Region;Innovare Academics Sciences Pvt. Ltd;2019-2020;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
709;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;35;71;689;5;71;0.08;19.69;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
710;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;;-;17;353;1215;9682;439;1215;0.34;27.43;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science
711;21101042009;Journal of Medical Pharmaceutical and Allied Sciences;journal;23207418;;-;2;26;0;718;0;0;0;27.62;India;Asiatic Region;;2020-2021;"Drug Discovery; Pharmaceutical Science; Pharmacology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
712;21101046187;Journal of Medicinal and Chemical Sciences;journal;26514702;;-;5;39;0;1230;0;0;0;31.54;France;Western Europe;Sami Publishing Company;2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Chemistry (miscellaneous); Drug Discovery; Molecular Medicine; Pharmaceutical Science"
713;21101037321;Khyber Medical University Journal;journal;23052643, 23052651;;-;2;64;0;1427;0;0;0;22.3;Pakistan;Asiatic Region;;2020-2021;"Dentistry (miscellaneous); Health Professions (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
714;21101039471;Korean Journal of Medicinal Crop Science;journal;22880186, 12259306;;-;3;41;0;1473;0;0;0;35.93;South Korea;Asiatic Region;Korean Society of Medicinal Crop Science;2020-2021;"Agronomy and Crop Science; Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmaceutical Science; Plant Science"
715;21101039878;Medicine in Drug Discovery;journal;25900986;;-;5;1;2;93;2;2;1;93;Netherlands;Western Europe;Elsevier BV;2019-2021;"Drug Discovery; Pharmacology; Pharmacology (medical)"
716;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;;-;21;7;25;793;49;0;2.25;113.29;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous); Molecular Medicine; Pharmaceutical Science; Pharmacology"
717;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;12;46;567;67;39;1.78;47.25;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
718;21496;Revista de Chimie (discontinued);journal;00347752;;-;31;535;2332;16555;1542;2332;0.68;30.94;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;"Chemistry (miscellaneous); Engineering (miscellaneous); Materials Chemistry; Materials Science (miscellaneous); Surfaces, Coatings and Films"
719;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;;-;6;26;169;423;29;169;0.11;16.27;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering; Drug Discovery"
720;21101023977;ScienceRise: Pharmaceutical Science;journal;25194844, 25194852;;-;6;44;0;1211;0;0;0;27.52;Ukraine;Eastern Europe;PC Technology Center;2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
721;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;;-;28;1700;112;55912;656;112;5.91;32.89;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science
722;21101039108;Uspehi Molekularnoj Onkologii;journal;2313805X, 24133787;;-;1;21;2;792;0;2;0;37.71;Russian Federation;Eastern Europe;ABC-press Publishing House;2019-2021;"Biochemistry (medical); Cancer Research; Genetics (clinical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
723;21101024226;WikiJournal of Medicine;journal;20024436;;-;1;6;0;311;0;0;0;51.83;United States;Northern America;;2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
